Hee Kyoung Jeon

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kévin Pethe, Pablo Bifani, Jichan Jang et al. · Nature Medicine · 2013 · 595 citations · Full text

Medicinal Chemistry, Potent Clinical Candidate, Pulmonary Tuberculosis +7

High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors

Thierry Christophe, Mary Jackson, Hee Kyoung Jeon et al. · PLoS Pathogens · 2009 · 322 citations · Full text

Antimicrobial Chemotherapy, Drug Resistance, Medicinal Chemistry +21

Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors

Marion Flipo, Matthieu Desroses, Nathalie Lecat‐Guillet et al. · Journal of Medicinal Chemistry · 2011 · 84 citations · Full text

Drug Target, Pharmacotherapy, Chemical Biology +17

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors

Marion Flipo, Matthieu Desroses, Nathalie Lecat‐Guillet et al. · Journal of Medicinal Chemistry · 2011 · 70 citations · Full text

High-Content Imaging of <i>Mycobacterium Tuberculosis</i> -Infected Macrophages: An <i>In Vitro</i> Model for Tuberculosis Drug Discovery

Thierry Christophe, Fanny Ewann, Hee Kyoung Jeon et al. · Future Medicinal Chemistry · 2010 · 60 citations

Engineering, Imaging Agent, Tuberculosis Prevention +22